Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma.
Ishihara N, Komatsu S, Sofue K, Ueshima E, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yanagimoto H, Toyama H, Ueda Y, Kodama Y, Murakami T, Fukumoto T.
Ishihara N, et al.
Hepatol Res. 2024 Feb 14. doi: 10.1111/hepr.14024. Online ahead of print.
Hepatol Res. 2024.
PMID: 38353524